openPR Logo
Press release

6th International Conference on HIV/AIDS, STDs and STIs

04-09-2018 03:45 PM CET | Health & Medicine

Press release from: Conference Series LLC Ltd

HIV AIDS Conferences | 70K Visitors | STD Events | Meetings | USA | Europe | Middle East | Aisa | 2018

HIV AIDS Conferences | 70K Visitors | STD Events | Meetings | USA | Europe | Middle East | Aisa | 2018

6th International Conference on HIV/AIDS, STDs and STIs is exclusively designed for immunologists & virologist, physicians, nurses/nurse practitioners, pharmacists, psychologists, behavioral researchers, Healthcare professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to STD AIDS research and business.
As HIV/AIDS is an alarming concern throughout the world, STD AIDS 2018 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues apart from this HIV Co-infection, HIV Current pharmaceutical design
As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Vinay Jetti
1- 702-508-5200
hiv-stds@immunologyconferences.org

San Francisco, USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 6th International Conference on HIV/AIDS, STDs and STIs here

News-ID: 1007789 • Views: 376

More Releases from Conference Series LLC Ltd

European Conference on Surgery & Cosmetology
It's our privilege to invite all the researchers, developers, and experts on behalf of committee members to be the part of the prestigious European Conference on Surgery & Cosmetology schedule on May 25-26, 2020 in Barcelona, Spain. We aim to unify all the people indulged in this vast field and share the knowledge, explore and look forward to the new way by integrating new thoughts and customizing the limits of
3rd Annual Congress on Diabetes and Its Complications
3rd Annual Conference on Diabetes and its Complications which is going to be held on December 4-5, 2019 at Tokyo Japan. This conference is in collaboration with Endocrinology conferences, Metabolomics conferences and diabetes Congress 2019. All diabetes experts and endocrinology experts will come to this prestigious congress of diabetes abd endocrinology. Diabetes conference 2019 will contains plenary talks, keynote talks, speaker talsk, student talks, exhibitors and sponsorships. We take great pleasure
This time in Brisbane Australia !!! Grand Surgeons Meet on June 19-20, 2019 | No …
With the unique feedback and generous response received from the attendees, we proudly announce the commencement of 13thInternational Conference on Surgery and Anaesthesia with the theme Accelerating next generation research in Surgery and Anaesthesia on June 19-20, 2018 in Brisbane, Australia. Targeting Doctors, Surgeons, Anesthesiologists, Dental surgeons, Residents Fellowship holders, Medical students, Healthcare industries, Nurses Surgical tool technicians etc. from different parts of the world to Brisbane, Australia with the
16th International Conference on Clinical Nutrition
Conference Series LLC LTD is glad to invite you to the 16th International Conference on Clinical Nutrition at Tokyo, Japan on April 24-25, 2019. This Clinical Nutrition Conference mainly focuses on the theme “Evolving Solutions in Clinical Nutrition”. Clinical Nutrition takes an initiative to provide health practitioners an understanding of the vital role of nutrition in healing and well-being. Clinical Nutrition 2019 is aimed to provide a distinguished opportunity to

All 5 Releases


More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral